Skip to main content
Premium Trial:

Request an Annual Quote

GE Expands Rights to Use, Sublicense Fisher BioImage's Green Fluorescent Protein


NEW YORK (GenomeWeb News) - GE Healthcare has obtained a license to use Fisher BioImage’s green fluorescent protein technology beyond life science research, GE said today.
 
The expanded licensing agreement expands GE's rights to develop and sell products using this technology and gives it the right to sublicense the IP.
 
Financial terms of the deal were not announced.
 
GFP is a fluorescent protein from the jellyfish Aequorea victoria and is applied in many areas of drug discovery and veterinary and plant science research.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.